Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin - sprookjes - yvandenbroek - TriplyDB

Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin

Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin

http://www.wikidata.org/entity/Q28208159

about

sameAs

Identification of the fibroblast growth factor (FGF)-interacting domain in a secreted FGF-binding protein by phage display Anaplastic lymphoma kinase: signalling in development and disease Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs ALK and ROS1 as targeted therapy paradigms and clinical implications to overcome crizotinib resistance Emerging importance of ALK in neuroblastoma Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth Activation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell lines Shc3 affects human high-grade astrocytomas survival Differential induction of glioblastoma migration and growth by two forms of pleiotrophin Molecular pathogenesis of peripheral neuroblastic tumors Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin ALK activation induces Shc and FRS2 recruitment: Signaling and phenotypic outcomes in PC12 cells differentiation Pleiotrophin/heparin-binding growth-associated molecule as a mitogen of rat hepatocytes and its role in regeneration and development of liver Anaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cells Gene expression profiling identifies regulatory pathways involved in the late stage of rat fetal lung development The pro-angiogenic cytokine pleiotrophin potentiates cardiomyocyte apoptosis through inhibition of endogenous AKT/PKB activity Mutation-introduced dimerization of receptor tyrosine kinases: from protein structure aberrations to carcinogenesis.Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence Tagless extraction-retentate chromatography: a new global protein digestion strategy for monitoring differential protein expression.The use of phage display in the study of receptors and their ligands.Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations.Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor.Suppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophin.ALK-rearrangements and testing methods in non-small cell lung cancer: a review Proteomic analysis of multiple myeloma: current status and future perspectives.Integrating in silico prediction methods, molecular docking, and molecular dynamics simulation to predict the impact of ALK missense mutations in structural perspective The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells.The role of pleiotrophin and beta-catenin in fetal lung development.Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein.A Pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPβ/ζ ALK-activating homologous mutations in LTK induce cellular transformation.Nuclear targeting by the growth factor midkine.Chromogenic in situ hybridization is a reliable assay for detection of ALK rearrangements in adenocarcinomas of the lung.

P2860

Q24293106-00F9F1E9-267A-4F78-978C-C96523A10BF8 Q24312329-EB32D7E5-FEDF-4BC9-9E03-D78A07AB151A Q24336817-55ABB401-94E8-4B47-BBB1-434822D4AEAC Q26769659-EAC09FED-8A08-4948-BB00-1DF19F28D1AA Q26775347-2DA03AF1-4FEC-4F66-A139-CEE4A7C1FB70 Q26858819-76645860-BA90-4B23-A2D3-30898418B7C0 Q27663479-3766CDDA-3AA1-4177-A16C-FF8F5F98342C Q28118071-CBA79C8D-E5AC-40A9-BCE1-8B616248B9D5 Q28214316-ED4D0E83-C1E0-4699-AE5B-45A8976E78A3 Q28214508-3B0C0A19-64A7-4549-A785-D2E3963C7720 Q28214927-153DEDA8-2B40-4FB6-A118-AF242EB5C21E Q28216327-F3E0975D-0562-4D8A-8D1C-A2CA9F2669BD Q28216536-2B3B6884-DECB-4394-ADD1-A4D504D0F9FA Q28218528-95A56B6D-AD96-454E-8BB8-F289C2023642 Q28248532-0EC75830-713C-4E3D-8D78-16CD8A0E39CA Q28252154-A118576E-F1AE-4562-BAEA-D26989274A0A Q28271405-9B54CAD9-6FD0-4986-B5FD-526087E5E354 Q28271787-BA3BEBCA-C9E3-44E3-B8F1-B43AAE4463B3 Q28564190-8C69A1A8-27C8-479A-8FF2-3BB354E74B6F Q28570482-75EC20EC-E218-4409-8897-AC236339B0AE Q28571575-E681DF86-0612-4866-9641-BD610B546DDE Q28580441-10D19D03-5ABC-47BD-8DD6-8D778692E809 Q28581466-28456783-3646-464C-B39A-299D33A1D0F8 Q30372506-25CFAEB1-972E-469E-BC87-247EB24D3AE0 Q30968725-0FCE4495-5519-4D92-9ECB-EE86C21CF301 Q31111488-1651A61B-8E14-47C2-A90C-06C3AA8F47AD Q31122757-FCE70F4C-1DE4-4D8C-9CFB-B85738F614A8 Q33304365-647DD4FE-FDF8-45F6-8358-24A12D682259 Q33487136-51CD0B6D-C7BB-41D8-AA70-3951AF8B295E Q33587989-5FA50E6B-476E-478B-8DBA-FE01E87AA6EC Q33776835-35873D6B-066A-4910-9B9B-1C0EBDEDDE39 Q33807327-314B620D-639D-4390-9D30-17C1A0F18C8C Q33903573-610E180C-CCC4-42D9-86AA-29C3BDA20D0D Q33915644-D695DABA-425F-47F5-92B8-A59CE92AA6D9 Q33981440-9FD4BAC0-27FD-49B9-A1C3-5F9C89526560 Q34087175-A16CC19A-1728-4DBB-BBAB-1B5B1744043E Q34114284-E1513DD4-04F2-40E9-A574-DF295E19EF63 Q34162940-476C8070-1E7F-439E-ADA4-C133D5AE5157 Q34286252-F91B30A6-6B25-4641-A81A-D7B9991627D0 Q34349164-A322C99F-8764-4072-AEF9-034EB54C1BD2

P2860

Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin

http://www.wikidata.org/entity/Q28208159

description

2001 nî lūn-bûn

@nan

2001 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Identification of anaplastic l ...... the growth factor pleiotrophin

@ast

Identification of anaplastic l ...... the growth factor pleiotrophin

@en

Identification of anaplastic l ...... the growth factor pleiotrophin

@nl

type

label

Identification of anaplastic l ...... the growth factor pleiotrophin

@ast

Identification of anaplastic l ...... the growth factor pleiotrophin

@en

Identification of anaplastic l ...... the growth factor pleiotrophin

@nl

prefLabel

Identification of anaplastic l ...... the growth factor pleiotrophin

@ast

Identification of anaplastic l ...... the growth factor pleiotrophin

@en

Identification of anaplastic l ...... the growth factor pleiotrophin

@nl

P1433

Q28208159-CA179E85-BFFD-41AB-B307-09055BDD960B

P1476

Q28208159-E0740796-2087-414B-B150-162F2B010300

P2093

Q28208159-2AEA5CF7-D200-45BF-9CBC-3C453BF1A25C

Q28208159-3DCD158A-E421-4370-8E90-D0E12EC07BEF

Q28208159-42E68A64-FE97-4B41-B5C1-0FC821B1AF19

Q28208159-56D6EF64-50A8-4706-9CB4-13E911927EF5

Q28208159-7BFAB047-A1CD-48C6-8BBB-125EF6D72753

Q28208159-7E88A5CF-31E5-4A48-8D36-BEFF6E5D05B8

Q28208159-80054684-69A0-47A4-84C3-6851F4888B99

Q28208159-93FF3B66-9034-41F5-9806-CD29F05DD0CE

Q28208159-B3CA2837-2F27-4DEB-B740-75853B706605

Q28208159-C3D1D43A-E4B0-4E03-B7B3-F74E5501D14C

P2860

Q28208159-013EDA6D-231E-4A64-BA33-8A638A0BF96F

Q28208159-0223A8DD-19AC-46C2-8C33-B7E795246AD2

Q28208159-0A1447D8-91CB-4A24-9232-2119CD5EC352

Q28208159-2138AE97-637E-4ED5-B01B-C7471A064888

Q28208159-213D9A1C-D14F-4B28-90CD-502BA62D9D61

Q28208159-2FB30268-40D8-4A1B-91B0-1301D71BD0F2

Q28208159-2FFCB14B-A107-4BBA-B9AD-05E56508E3A8

Q28208159-46DE9862-45D3-4282-AA12-BBE7977A3511

Q28208159-4A6D095F-3AF2-4E23-9786-F0B6D4966F8A

Q28208159-60CD16E3-2C26-4CBC-8896-3F4AE59EA123

P304

Q28208159-7916A2BD-BC7C-45FC-9364-34CB36AA56E0

P31

Q28208159-29F7FD92-CEF2-4F10-A29F-029884EF52AE

P3181

Q28208159-6C8DC140-9AE5-42AA-908B-E63537671BCC

P356

Q28208159-92BDAE63-0EA4-4B1D-B057-91F74A597A5A

P407

Q28208159-49F11544-0F54-4EDF-9CBC-72E21C65A0CA

P433

Q28208159-7D06FF8E-3363-4838-92FE-3ABDDF5479A4

P478

Q28208159-FE73AC2F-91F2-4AD9-84AA-F38F285B1FA4

P577

Q28208159-90F10BDC-BFBF-4178-AC0A-3E58514E854F

P5875

Q28208159-FB845FC1-0916-4F5D-97C3-8B124F2702AE

P698

Q28208159-EE3EDF2A-9F46-4B96-B7D6-0DF4F0DCF6A8

P3181

P356

P1433

Journal of Biological Chemistry

P1476

Identification of anaplastic l ...... the growth factor pleiotrophin

@en

P2093

A Aigner

http://www.w3.org/2001/XMLSchema#string

A Karavanov

http://www.w3.org/2001/XMLSchema#string

A Kuo

http://www.w3.org/2001/XMLSchema#string

A T Riegel

http://www.w3.org/2001/XMLSchema#string

A Wellstein

http://www.w3.org/2001/XMLSchema#string

B Souttou

http://www.w3.org/2001/XMLSchema#string

C Malerczyk

http://www.w3.org/2001/XMLSchema#string

D J Caughey

http://www.w3.org/2001/XMLSchema#string

D Wen

http://www.w3.org/2001/XMLSchema#string

G E Stoica

http://www.w3.org/2001/XMLSchema#string

P2860

Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis

The phosphatidylinositol 3' kinase pathway is required for the survival signal of leukocyte tyrosine kinase

ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity

Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity

Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5)

Cell signaling by receptor tyrosine kinases

Regulation of phosphoinositide-specific phospholipase C isozymes

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

Human ryudocan from endothelium-like cells binds basic fibroblast growth factor, midkine, and tissue factor pathway inhibitor

P304

16772-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3627354

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M010660200

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

276

http://www.w3.org/2001/XMLSchema#string

P577

2001-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12054230

http://www.w3.org/2001/XMLSchema#string

P698

11278720

http://www.w3.org/2001/XMLSchema#string